4-bis(2'-hydroxyethyl)amino-N-tert-butyloxycarbonylaniline | 244247-69-6

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 4-bis(2'-hydroxyethyl)amino-N-tert-butyloxycarbonylaniline
• 英文别名: tert-butyl (4-(bis(2-hydroxyethyl)amino)phenyl)carbamate；4-[bis(2-hydroxyethyl)amino]-N-(tert-butoxycarbonyl)aniline；tert-butyl N-[4-[bis(2-hydroxyethyl)amino]phenyl]carbamate
• CAS: 244247-69-6
• 化学式: C₁₅H₂₄N₂O₄
• 分子量: 296.367
• InChiKey: BZXFSSIIYRKOBZ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.2
• 重原子数：
  21
• 可旋转键数：
  8
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.53
• 拓扑面积：
  82
• 氢给体数：
  3
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  4-bis(2'-hydroxyethyl)amino-N-tert-butyloxycarbonylaniline 在 4-二甲氨基吡啶 、 三乙胺 、 lithium bromide 作用下， 以 四氢呋喃 、 二氯甲烷 为溶剂， 生成 4-bis(2'-bromoethyl)amino-N-tert-butyloxycarbonylaniline
  参考文献：
  名称：

  Self-Immolative Nitrogen Mustards Prodrugs Cleavable by Carboxypeptidase G2 (CPG2) Showing Large Cytotoxicity Differentials in GDEPT

  摘要：

  Nineteen novel potential self-immolative prodrugs and their corresponding drugs have been synthesized for gene-directed enzyme prodrug therapy (GDEPT) with carboxypeptidase G2 (CPG2) as the activating enzyme. The compounds are derived from o- and p-amino and p-methylamino aniline nitrogen mustards. Their aqueous stability, kinetics of drug release by CPG2, and cytotoxicity in the colon carcinoma cell line WiDr, expressing either surface-tethered CPG2 (stCPG2(Q)3) or control beta-galactosidase, are assessed. The effect of various structural features on stability, kinetics of activation, and biological activity is discussed. The p-methylamino prodrugs are the most stable compounds from this series, with the largest cytotoxicity differentials between CPG2-expressing and nonexpressing cells. The most potent compounds in all series are prodrugs of bis-iodo nitrogen mustards. 4-{N-[4'-Bis(2"-iodoethyl)aminophenyll-N'-methylcarbamoyloxymethyl}phenylcarbamoyl-L-glutamic acid, compound 39b, is 124-fold more cytotoxic to WiDr cells expressing CPG2 than to cells expressing beta-galactosidase. An additional six compounds show better cytotoxicity differential than the published N-{4-[(2-chloroethyl)(2-mesyloxyethyl)amino]benzoyl}-L-glutamic acid (CMDA) prodrug.

  DOI：

  10.1021/jm020462i
• 作为产物：
  描述：

  N-(4-硝基苯基)二乙醇胺 在 palladium on activated charcoal 咪唑 、 triethylamine trihydrofluoride 、 氢气 作用下， 以 四氢呋喃 、 N,N-二甲基甲酰胺 为溶剂， 反应 42.0h， 生成 4-bis(2'-hydroxyethyl)amino-N-tert-butyloxycarbonylaniline
  参考文献：
  名称：

  Self-Immolative Nitrogen Mustards Prodrugs Cleavable by Carboxypeptidase G2 (CPG2) Showing Large Cytotoxicity Differentials in GDEPT

  摘要：

  Nineteen novel potential self-immolative prodrugs and their corresponding drugs have been synthesized for gene-directed enzyme prodrug therapy (GDEPT) with carboxypeptidase G2 (CPG2) as the activating enzyme. The compounds are derived from o- and p-amino and p-methylamino aniline nitrogen mustards. Their aqueous stability, kinetics of drug release by CPG2, and cytotoxicity in the colon carcinoma cell line WiDr, expressing either surface-tethered CPG2 (stCPG2(Q)3) or control beta-galactosidase, are assessed. The effect of various structural features on stability, kinetics of activation, and biological activity is discussed. The p-methylamino prodrugs are the most stable compounds from this series, with the largest cytotoxicity differentials between CPG2-expressing and nonexpressing cells. The most potent compounds in all series are prodrugs of bis-iodo nitrogen mustards. 4-{N-[4'-Bis(2"-iodoethyl)aminophenyll-N'-methylcarbamoyloxymethyl}phenylcarbamoyl-L-glutamic acid, compound 39b, is 124-fold more cytotoxic to WiDr cells expressing CPG2 than to cells expressing beta-galactosidase. An additional six compounds show better cytotoxicity differential than the published N-{4-[(2-chloroethyl)(2-mesyloxyethyl)amino]benzoyl}-L-glutamic acid (CMDA) prodrug.

  DOI：

  10.1021/jm020462i

文献信息

• Introducing a squaramide-based self-immolative spacer for controlled drug release
  作者：Marta Ximenis、Angel Sampedro、Luis Martínez-Crespo、Guillem Ramis、Francisca Orvay、Antonio Costa、Carmen Rotger

  DOI：10.1039/d0cc07683j

  日期：——

  Herein we report the design, synthesis and assessment of the first example of a squaramide-based self-immolative system triggered by an enzymatic reduction. We have proved that the release of the alkylating agent N′,N′-(bis(2-chloroethyl)benzene)-1,4-diamine (ANM) provokes a dramatic reduction of the survival factor in glioblastoma cells, evidencing the suitability of the squaramide-based spacer for drug

  本文中，我们报告了由酶促还原反应引发的基于方胺的自燃系统的第一个实例的设计，合成和评估。我们已经证明，烷基化剂N ′，N ′ -（双（2-氯乙基）苯）-1,4-二胺（ANM）的释放引起胶质母细胞瘤细胞中生存因子的显着降低，证明了其适用性。基于方胺的间隔基，用于药物输送应用。
• Anti-tumor agents
  申请人：Astrazeneca AB

  公开号：US06472435B1

  公开（公告）日：2002-10-29

  The invention concerns anti-tumor agents of formula (I), wherein each of R1, R2 and R3 has the meanings defined in the specification including hydrogen, (1-4C)alkyl, (3-4C)alkynyl and (1-4C)alkoxyl; each of R4 and R5 is (1-4C) alkyl; each of R6 and R7 is hydrogen or (1-4C)alkyl; X is N-(1-4C)alkylimino, N-(3-4C)alkenylimino, or (3-4C)alkynylimino; m is 1 or 2 and each R8 is as defined in the specification; each Y′ and Y2 is halogen, (1-4C)alkanesulphonyloxy, benzensulphonyloxy or phenyl-(1-4C)alkanesulfonyloxy; or a pharmaceutical acceptable salt thereof; provided that at least one of R1, R2 and R3 is other than hydrogen; a process for their preparation, pharmaceutical composition containing them and their use for producing an anti-proliferative effect in a warm-blooded animal.

  该发明涉及式(I)的抗肿瘤剂，其中R1、R2和R3中的每一个具有规范中定义的含氢、(1-4C)烷基、(3-4C)炔基和(1-4C)烷氧基等含义；R4和R5中的每一个是(1-4C)烷基；R6和R7中的每一个是氢或(1-4C)烷基；X是N-(1-4C)烷基亚胺基、N-(3-4C)烯基亚胺基或(3-4C)炔基亚胺基；m为1或2，每个R8如规范中定义；每个Y'和Y2是卤素、(1-4C)烷磺酰氧基、苯基磺酰氧基或苯基-(1-4C)烷磺酰氧基；或其药学上可接受的盐；前提是R1、R2和R3中至少有一个不是氢；一种制备它们的方法，含有它们的药物组合物以及它们用于在温血动物中产生抗增殖效应的用途。
• US6472435B1
  申请人：——

  公开号：US6472435B1

  公开（公告）日：2002-10-29